Replies to post #225986 on Biotech Values

[DewDiligence]

…the biotech market has become exponentially more illogical, possibly driven by the sheer number of companies that has diluted the focus of serious investors.

Compared to when? If your “control arm” is pre-2014 (e.g.), I’m inclined to agree with your contention.